Half of children given ‘skinny jab’ no longer clinically obese, study finds

Semaglutide is also known as Ozempic. Photograph: George Frey/Reuters

Nearly half of children who were assigned the “skinny jab” lost enough weight to no longer be classed as clinically obese, according to research.

The study, led by Dr Aaron Kelly, the co-director of the Center for Pediatric Obesity Medicine at the University of Minnesota, looked at 201 adolescents who were classed as clinically obese.